2015
DOI: 10.1002/uog.14755
|View full text |Cite
|
Sign up to set email alerts
|

Impact on obstetric outcome of third‐trimester screening for small‐for‐gestational‐age fetuses

Abstract: Objectives To evaluate the performance of screening for small-for-gestational-age (SGA) fetuses by ultrasound biometry at 30-35 weeks' gestation, and to

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
15
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(15 citation statements)
references
References 23 publications
0
15
0
Order By: Relevance
“…Nevertheless, the performance of SFH measurement for the identification of abnormal fetal growth has been shown to be poor. As an alternative, universal third‐trimester screening to determine estimated fetal weight centile (EFWc) is also offered in some countries, and has shown better performance than SFH, but still, can only identify around half or less of small fetuses.…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, the performance of SFH measurement for the identification of abnormal fetal growth has been shown to be poor. As an alternative, universal third‐trimester screening to determine estimated fetal weight centile (EFWc) is also offered in some countries, and has shown better performance than SFH, but still, can only identify around half or less of small fetuses.…”
Section: Introductionmentioning
confidence: 99%
“…Fetal growth restriction and being small-for-gestational age (SGA) are major causes of adverse perinatal outcome [1][2][3] . Ultrasound is the method commonly used in practice for SGA screening; however, screening accuracy is variable between studies and is relatively poor [4][5][6][7][8][9][10][11][12] . Biometric measurements are reported on the basis of fetal growth curves.…”
Section: Introductionmentioning
confidence: 99%
“…Yet, there has been considerable controversy about the need for serial biometry measurements during pregnancy [9,10], and at the present time, professional organizations do not recommend this approach [11]. Controversies include: which reference range or standard to use for fetal size and growth (e.g., local vs. international) [1215], the timing at which fetal biometry should be obtained [16], the need for serial measurements [17], which specific anatomic parameters to monitor (e.g., abdominal circumference, head circumference, estimated fetal weight), and the precise cutoff points to identify abnormalities. Moreover, the diagnostic endpoint is also a subject of controversy.…”
Section: Introductionmentioning
confidence: 99%